Elisa ten Hacken

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

25h-index2.3kcitations120works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(88), Lymphoma Diagnosis and Treatment(29), Immunodeficiency and Autoimmune Disorders(17), Acute Lymphoblastic Leukemia research(15), Immune Cell Function and Interaction(15)

Publications120 total

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies
Journal of Hematology & Oncology·2026Open Access
CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies
Figshare·2026Open Access
Additional file 1 of CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies
Figshare·2026Open Access
Additional file 1 of CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies
Figshare·2026Open Access
CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies
Figshare·2026Open Access
Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
2025Open Access
Supplementary Data from Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models
2025Open Access
Supplementary Figures from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
2025Open Access
Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy
Blood·2025Open Access
EXABS-154-CLL: Richter's Syndrome: Preclinical Insight
Clinical Lymphoma Myeloma & Leukemia·2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway
JCI Insight·2025· 1 citedOpen Access
A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation
Frontiers in Immunology·2025· 1 citedOpen Access
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations
Blood·2025· 9 citedOpen Access
Impaired Response to Oxidative DNA Damage Underlies Genomic Instability in B-Cell Leukemia Driven By <i>RPS15</i> Mutation
Blood·2024· 2 cited
Polyfunctional Effector PD-1+ CD8+ T Cells and M1 Macrophages Promote Immune Checkpoint Blockade Response in Richter Syndrome Mouse Models
Blood·2024· 1 cited
Topic Modeling of Genotyping of Transcriptomes Reveals Collaboration between BTKC481S-Mutant and Wild Type Cells in Btki-Resistant Chronic Lymphocytic Leukemia
Blood·2024· 1 citedOpen Access
Updates on the biology of chronic lymphocytic leukemia: introductory editorial
Seminars in Hematology·2024· 1 citedOpen Access
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia
Blood·2024· 7 cited
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial
Seminars in Hematology·2024Open Access
Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing
STAR Protocols·2023· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Catherine J. Wu(24), Donna Neuberg(19), Jan A. Burger(17), Paolo Ghia(14), Kenneth J. Livak(12), Ruben D. Carrasco(12), Federico Caligaris‐Cappio(12), María Hernández‐Sánchez(11), Cristina Scielzo(11), Shanye Yin(10), Elizabeth Witten(9), Maria Teresa Sabrina Bertilaccio(8), Michaela Gruber(8), Gabriela Brunsting Hoffmann(8), Gad Getz(7), Maurilio Ponzoni(7), Lydia Scarfò(7), Erin M. Parry(7), Robert Redd(7), Matthew S. Davids(6)